Drug ID: | NPD6238 |
Drug Name: | SQ-33351 |
Molecular Formula: | C25H27F3N2O4 |
Canonical SMILES: | COc1ccc(cc1)[C@@H]1Cc2c(N(C(=O)[C@@H]1OC(=O)C)C[C@@H]1CCCN1)cccc2C(F)(F)F |
Standard InCHI: | InChI=1S/C25H27F3N2O4/c1-15(31)34-23-19(16-8-10-18(33-2)11-9-16)13-20-21(25(26,27)28)6-3-7-22(20)30(24(23)32)14-17-5-4-12-29-17/h3,6-11,17,19,23,29H,4-5,12-14H2,1-2H3/t17-,19-,23+/m0/s1 |
Standard InCHIKey: | LMMFNPFUDYQJEK-WCAVRKLYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB003989 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 476.19 |
ALogP | -0.8353 |
MLogP | 3.22 |
XLogP | 5.161 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 12 |
TPSA | 67.87 |
RO5 Violation | 1 |